Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rocío Silva‑Cruz"'
Autor:
Lucina Bobadilla‑Morales, Víctor Manuel Maciel Gutiérrez, Uriel Francisco Santana‑Bejarano, Rocío Silva‑Cruz, Helia Judith Pimentel‑Gutiérrez, Citlalli Ortega‑de-la-Torre, Manuel Willebaldo Centeno Flores, Karina Franco Topete, Alfredo Corona Rivera, Betsy Annel González‑Quezada, Juan Armendáriz Borunda, Jorge Rivera, Ramón Franco Topete
Publikováno v:
Oncology Letters.
Colorectal cancer (CRC) is the fourth leading worldwide cause of cancer-associated mortalities. Nuclear factor-κB (NF-κB) is a transcriptional regulator of multiple genes associated with CRC. Tumor tissue were compared with normal adjacent mucosa f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::880614592589b15afc1ec0bd96df7095
https://doi.org/10.3892/ol.2018.8201
https://doi.org/10.3892/ol.2018.8201
Autor:
Alfredo Corona-Rivera, Jorge Román Corona-Rivera, Mireya Orozco-Vela, Moisés Quiles-Corona, Francisco Javier Martínez-Macías, Rocío Silva-Cruz, Janet González-Cruz, Christian Peña-Padilla, Fernando Velarde-Rivera, Lucina Bobadilla-Morales
Publikováno v:
American journal of medical genetics. Part A. 173(4)
The usefulness of the complete blood count (CBC) during the first week of life in infants with Down syndrome (DS) has been recognized; however, studies are limited and have evaluated only some of the parameters of the CBC. Here, we report a prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1923e02024150a61e8cd68a500002a1a
https://pubmed.ncbi.nlm.nih.gov/28168815
https://pubmed.ncbi.nlm.nih.gov/28168815
Autor:
Helia Judith Pimentel-Gutiérrez, Rocío Silva-Cruz, Fernando Sánchez-Zubieta, Jorge Román Corona-Rivera, Citlalli Ortega-de-la-Torre, César Cenobio Barba-Barba, Lucina Bobadilla-Morales, Juan Armendáriz-Borunda, Betsy Annel González-Quezada, Alfredo Corona-Rivera
Publikováno v:
Oncology letters. 12(5)
Acute lymphoblastic leukemia (ALL) accounts for 30% of all pediatric cancers. Currently available treatments exhibit toxicity and certain patients may develop resistance. Thus, less toxic and chemoresistance-reversal agents are required. In the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e8ae2d33d90fbf7f7ce173a8a61700
https://pubmed.ncbi.nlm.nih.gov/27895780
https://pubmed.ncbi.nlm.nih.gov/27895780
Autor:
Jenny A Paniagua-Padilla, Lucina Bobadilla-Morales, Alfredo Corona-Rivera, Citlalli Ortega-de-la-Torre, Helia Judith Pimentel-Gutiérrez, Oscar Gonzalez-Ramella, Sergio Gallegos-Castorena, Rocío Silva-Cruz, Abraham Zepeda-Moreno, Fernando Sánchez-Zubieta, Jorge Román Corona-Rivera
Publikováno v:
Molecular Cytogenetics
Here we present a male patient with acute myeloid leukemia (AML) initially diagnosed as M5 and with karyotype 46,XY. After induction therapy, he underwent a HLA-matched allogeneic hematopoietic stem cell transplantation, and six years later he relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0efd305c8a51f5bd13ba6ca96ee87369
https://doi.org/10.1186/s13039-014-0105-4
https://doi.org/10.1186/s13039-014-0105-4